Live Breaking News & Updates on Ankylosing Spondylitis Bechterews Disease

Stay updated with breaking news from Ankylosing spondylitis bechterews disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Approves Secukinumab for Adults With HS

This marks the second FDA-approved agent for the condition, and the first IL-17A inhibitor. ....

San Francisco , United States , Pp Haley Naik , Secukinumab Cosentyx , Drug Administration , University Of California , Hidradenitis Suppurativa Clinical Response , Hidradenitis Suppurativa , Plaque Psoriasis , Psoriatic Arthritis , Ankylosing Spondylitis Bechterews Disease , Skin And Soft Tissue Infection , Us Food And Drug Administration , Nited States Food And Drug Administration , Clinical Research , Clinical Trials , Linical Studies ,

FDA Approves Bimekizumab for Plaque Psoriasis in Adults

Bimekizumab is the first IL-17A and IL-17F inhibitor approved by the FDA for adults with psoriasis. ....

New York , United States , Mark Lebwohl , European Union , Icahn School Of Medicine At Mount Sinai , National Psoriasis Foundation , Drug Administration , National Psoriasis , Icahn School , Mount Sinai , New York City , Psoriasis Area , Severity Index , Global Assessment , Psoriatic Arthritis , Plaque Psoriasis , Us Food And Drug Administration , Nited States Food And Drug Administration , Skin And Soft Tissue Infection , Upper Respiratory Infection , Fungal Infection , Ankylosing Spondylitis Bechterews Disease , Oint Inflammation ,

FDA Approves Intravenous Formulation of Secukinumab

This new route of administration is expected to become available during the fourth quarter of 2023. ....

Philipj Mease , Christy Siegel , University Of Washington , School Of Medicine , Drug Administration , Swedish Medical Center , Psoriatic Arthritis , Intravenous Iv , Ankylosing Spondylitis , Biologic Therapy , Oint Inflammation , Tnf Alpha , Tumor Necrosis Factor Alpha , Umor Necrosis Factor Tnf , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology , Ankylosing Spondylitis Bechterews Disease ,

FDA OKs Ninth Humira Biosimilar, With Interchangeability

The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with interchangeability status. It will be available later this month. ....

United States , University Of Texas Southwestern Medical Center , Roy Fleischmann , Drug Administration , Texas Southwestern Medical Center , Rheumatoid Arthritis , Biologic Therapy , Biosimilar Drugs , Follow On Biologics , Psoriatic Arthritis , Hidradenitis Suppurativa , Ulcerative Colitis , Ankylosing Spondylitis , Crohns Disease , Ankylosing Spondylitis Bechterews Disease , Axial Spondyloarthritis Axspa , Juvenile Rheumatoid Arthritis , Oint Inflammation ,

CV Disease, Drug Abuse Big Contributors to Mortality in AS

Congestive heart failure and renal disease were the strongest contributing comorbidities to mortality in hospitalized patients with ankylosing spondylitis. ....

Eli Lilly , Mohamad Bittar , Cerner Health Facts Database , University Of Tennessee Health Science Center , Cerner Health Facts , Tennessee Health Science Center , Ankylosing Spondylitis , Heart Failure , Ankylosing Spondylitis Bechterews Disease , Renal Disease , Kidney Disease , Kidney Disorder , Renal Disorder , Drug Abuse , Congestive Heart Failure , Respiratory Failure , Myocardial Infarction , Body Mass Index Bmi , Cardiac Arrest , Cardiovascular Disease , Vd Cardio ,